Science
GyreOx’s platform technology is a combined chemistry / synthetic biology process, protected by 4 patent applications, allowing rapid access to novel and drug-like Gyrocycle™ macrocyclic peptides for hit-to-lead drug discovery.
Unmet Clinical Need
Unmet Clinical Need

Opportunities exist for new therapeutic modalities that can address complex intracellular targets

read more
Our Technology
Our Technology

Our biotransformation toolkit consists of a set of proprietary enzymes performing specific chemistries on a broad range of substrates

read more
Gyrocycle™ macrocylic peptides
Gyrocycle™ macrocylic peptides

Proprietary technology leads to Gyrocycle™ highly modified macrocyclic peptides

read more
Intellectual Property
Intellectual Property

GyreOx has protected its proprietary technology with four families of patent applications, with some now granted, covering both rationally engineered enzymes and the gyrocycle production process.

read more
Publications
Publications

GyreOx's technology is based on many years of collaborative research from scientists at the Universities of Oxford, Aberdeen and St Andrews.

read more